MTOR and neoplasm: The finding that the mTOR antagonist rapamycin, in contrast to other immunosuppressants, encourages tumor reduction in transplant patients afflicted with KSHV-based Kaposi sarcoma [129] underlines the significance of mTOR signaling cascade in KSHV activity.